545
Participants
Start Date
January 31, 2004
Primary Completion Date
October 31, 2004
Study Completion Date
October 31, 2004
Eszopiclone
Eszopiclone 3 mg QD
Placebo
Placebo tablet
Birmingham
Peoria
Tucson
Fayetteville
Garden Grove
Irvine
Northridge
Riverside
San Diego
Wheat Ridge
New Britian
Jacksonville
Miami
Miami Beach
North Miami
St. Petersburg
Atlanta
Augusta
Decatur
Smyrna
Boise
Overland Park
Rockville
Boston
Braintree
Brighton
Brockton
Cambridge
Watertown
Farmington Hills
St Louis
Omaha
Clementon
Morestown
Lawerence
New York
The Bronx
Durham
Winston-Salem
Bismarck
Beachwood
Cincinnati
Dayton
Oklahoma City
Eugene
Portland
Salem
Springfield
Conshohocken
Emmaus
Philadelphia
Scotland
Anderson
Madison
Memphis
Selmer
Austin
San Antonio
Wichita Falls
Salt Lake City
Richmond
Lakewood
Seatle
Spokane
Madison
Sumitomo Pharma America, Inc.
INDUSTRY